---
title: "Longshenrongfa Pharmaceutical Industry: The holding subsidiary Guofang Testing has obtained the CNAS laboratory accreditation certificate"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/243585452.md"
description: "Longshenrongfa Pharmaceutical Industry announced that its holding subsidiary Gansu Pharmaceutical Group Guofang Testing Co., Ltd. recently received the laboratory accreditation certificate awarded by the China National Accreditation Service for Conformity Assessment (CNAS). The acquisition of the CNAS laboratory accreditation certificate indicates that the management and technical capabilities of Guofang Testing Laboratory have been recognized at both national and international levels, which will have a positive impact on the company's future operations. The acquisition of this certificate will not have a significant impact on the company's current operating performance"
datetime: "2025-06-08T08:23:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/243585452.md)
  - [en](https://longbridge.com/en/news/243585452.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/243585452.md)
generator: "portal-rs"
---

# Longshenrongfa Pharmaceutical Industry: The holding subsidiary Guofang Testing has obtained the CNAS laboratory accreditation certificate

Longshenrongfa Pharmaceutical Industry announced that its holding subsidiary, Gansu Pharmaceutical Group Guofang Testing Co., Ltd., recently received the laboratory accreditation certificate awarded by the China National Accreditation Service for Conformity Assessment (CNAS). The acquisition of the CNAS laboratory accreditation certificate indicates that the management and technical capabilities of Guofang Testing Laboratory have been recognized at both national and international levels, which will have a positive impact on the company's future operations. The acquisition of this certificate will not have a significant impact on the company's current operating performance

### Related Stocks

- [300534.CN](https://longbridge.com/en/quote/300534.CN.md)

## Related News & Research

- [Cell C publishes FY2026 annual report](https://longbridge.com/en/news/296585950.md)
- [Thales, Systematic partner to boost Danish air defense capabilities](https://longbridge.com/en/news/296363485.md)
- [Rein Therapeutics releases corporate presentation on LTI-03 idiopathic pulmonary fibrosis program](https://longbridge.com/en/news/296389731.md)
- [Inepar board reviews related-party queries, awaits PP&C audit report by end-August](https://longbridge.com/en/news/296648529.md)
- [Steadright says Morocco TitanBeach titanium project begins pilot plant infrastructure work](https://longbridge.com/en/news/296489725.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**